Updated Dec. 7, 2012 at 11:11 a.m.

Premium Lock GSK, other firm's potential childhood cancer drugs undergo review

Published: 2012-12-07 11:10:00
Updated: 2012-12-07 11:11:15

Cancer research Cancer research Image 1 of 2 · Next Image…

Medicines from GlaxoSmithKline, Amgen, Threshold Pharmaceuticals and Boehringer Ingelheim GmbH have the potential to treat children with a variety of tumors and fast-spreading leukemia....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll